Related Experiment Video
Updated: Feb 15, 2026

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Premature polyadenylation of MAGI3 is associated with diminished N6-methyladenosine in its large internal exon
Thomas K Ni1,2,3, Jessica S Elman1,2,3, Dexter X Jin4,5
1Department of Developmental, Chemical and Molecular Biology, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA, 02111, USA.
Abstract:
In cancer, tumor suppressor genes (TSGs) are frequently truncated, causing their encoded products to be non-functional or dominant-negative. We previously showed that premature polyadenylation (pPA) of MAGI3 truncates the gene, switching its functional role from a TSG to a dominant-negative oncogene. Here we report that MAGI3 undergoes pPA at the intron immediately downstream of its large internal exon, which is normally highly modified by N6-methyladenosine (m6A). In breast cancer cells that upregulate MAGI3 pPA , m6A levels in the large internal exon of MAGI3 are significantly reduced compared to cells that do not express MAGI3 pPA . We further find that MAGI3 pPA transcripts are significantly depleted of m6A modifications, in contrast to highly m6A-modified full-length MAGI3 mRNA. Finally, we analyze public expression data and find that other TSGs, including LATS1 and BRCA1, also undergo intronic pPA following large internal exons, and that m6A levels in these exons are reduced in pPA-activated breast cancer cells relative to untransformed mammary cells. Our study suggests that m6A may play a role in regulating intronic pPA of MAGI3 and possibly other TSGs, warranting further investigation.
Insights
Tumor suppressor genes (TSGs) can become oncogenes via premature polyadenylation (pPA). Reduced N6-methyladenosine (m6A) modification in MAGI3 and other TSGs correlates with pPA, suggesting m6A regulates this oncogenic switch.
Area of Science:
- Molecular Biology
- Cancer Genetics
- RNA Biology
Background:
- Tumor suppressor genes (TSGs) are crucial for preventing cancer but can be inactivated through truncation.
- Premature polyadenylation (pPA) of the MAGI3 gene truncates its product, converting it from a TSG to a dominant-negative oncogene.
- N6-methyladenosine (m6A) is a key RNA modification influencing gene expression and RNA fate.
Purpose of the Study:
- To investigate the role of m6A modification in the pPA of MAGI3.
- To determine if m6A regulates intronic pPA in other TSGs.
- To explore the link between m6A levels and TSG function in breast cancer.
Main Methods:
- Analysis of MAGI3 gene expression and m6A modification levels in breast cancer cells.
- Comparison of m6A abundance in MAGI3 transcripts with and without pPA.
- Bioinformatic analysis of public expression data for other TSGs (LATS1, BRCA1) in breast cancer versus normal mammary cells.
Main Results:
- MAGI3 undergoes intronic pPA downstream of a large exon heavily modified by m6A.
- Breast cancer cells with MAGI3 pPA show reduced m6A levels in the MAGI3 exon and transcripts.
- Other TSGs (LATS1, BRCA1) also exhibit intronic pPA after large exons, with decreased m6A in cancer cells.
Conclusions:
- Reduced m6A modification in specific exons correlates with intronic pPA of MAGI3 and other TSGs in breast cancer.
- m6A may function as a regulatory mechanism controlling intronic pPA of TSGs.
- Further research is warranted to elucidate the precise role of m6A in TSG regulation and cancer development.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Internal Energy
Internal Energy
Internal Receptors
International System of Units
Prefixes are used to define both larger and smaller quantities in the SI system. For example, milli, micro, and nano define smaller quantities, while kilo, mega, and giga are used to define...
Internal and External Forces

